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ABSTRACT
Nosocomial bacterial infections caused by carbapenem-resistant Klebsiella pneumoniae 
(CRKP) is associated with high mortality in neurosurgical patients. There are few reports 
in the literature on meningitis caused by CRKP. We report two cases of CRKP meningitis 
after neurosurgery. The K. pneumoniae identification and antimicrobial susceptibility testing 
were performed using the Vitek Compact System. Minimum inhibitory concentrations of 
polymyxin B were determined using the broth microdilution method. Molecular typing of 
K. pneumoniae isolates was investigated using multilocus sequence typing. Antimicrobial 
susceptibility testing showed that the K. pneumoniae isolates were multidrug resistant and co-
produced extended-spectrum β-lactamases and KPC enzymes. The patients were treated with 
intrathecal polymyxin. Genetic polymorphism analyses revealed two different K. pneumoniae 
clones (ST1298 and ST2687), which were observed for the first time in CRKP infections. 
We recommend intravenous administration of intrathecal polymyxin for treating meningitis 
caused by multidrug-resistant K. pneumoniae. 
KEYWORDS: Meningitis. Klebsiella pneumoniae. Carbapenem-resistant. Beta-lactamases. 
Cerebrospinal fluid. 
INTRODUCTION
Meningitis refers to several infections defined as inflammation of the meninges; 
it may be caused by various infectious agents, including bacteria, viruses, parasites, 
fungi and non-infectious processes. Although viral meningitis is the most common, 
bacterial meningitis may be more severe and potentially life-threatening1. In recent 
years, carbapenem-resistant Klebsiella pneumoniae (CRKP) has become endemic 
and is one of the biggest public health concerns globally2,3. However, there are few 
reports in the literature on meningitis caused by CRKP4,5. We report two cases of 
post-neurosurgical nosocomial meningitis due to CRKP that were successfully 
treated with polymyxin.
MATERIALS AND METHODS
Clinical data were obtained from medical records. Bacterial identification and 
antimicrobial susceptibility testing were performed using the Vitek 2 Compact 
System® (bioMérieux, Marcy L’Étoile, France). The polymyxin B minimum 
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inhibitory concentrations (MICs) were determined using 
the reference Clinical Laboratory Standards Institute broth 
microdilution method6. Genes coding for extended-spectrum 
β-lactamases (bla-CTX-M, bla-TEM, bla-SHV), carbapenemases 
(bla-KPC, bla-OXA-48), and metallo-β-lactamases (bla-NDM-1, 
bla-IMP, bla-VIM) were investigated using the polymerase 
chain reaction, as described previously7-9. Molecular typing 
was performed by multilocus sequence typing (MLST)10.
CASE REPORTS
Case 1
A 17-year-old man from Campo Grande, Mato Grosso 
do Sul State, Brazil, was admitted to the emergency 
room after a car accident. On admission, the patient was 
sedated and intubated and had a heart rate of 90 beats/min, 
respiratory rate of 17 breaths/min, arterial blood pressure of 
160/90 mmHg, Glasgow Coma Scale (GCS) score of 3/15 
and APACHE index of 17. The skull computed tomography 
(CT) revealed cerebral edema with post-traumatic 
hydrocephalus, frontal lobe contusion and subarachnoid 
hemorrhage (grade IV on the Fisher scale).
An external ventricular shunt was inserted. The patient 
developed anisocoria and miotic pupils. Besides diffuse 
edema noted on a new CT, decompressive craniotomy was 
necessary. He also underwent various invasive procedures 
during hospitalization, including tracheostomy, central 
venous catheterization, urinary catheterization, enteral 
nutrition and mechanical ventilation. On postoperative 
day 3, the patient developed septic shock, probably from 
skin and fascial breast foci. Cerebrospinal fluid (CSF) 
examination revealed no abnormalities (Table 1). However, 
head CT revealed opacification of the left maxillary and 
ethmoidal sinuses. Intravenous (IV) meropenem, 1 g/8 h 
was administered. Clinical improvement and of the 
consciousness level was noted (GCS 8). On hospitalization 
day 11, his level of consciousness deteriorated again (GCS 
score decreased to 3/15); he presented with hyperthermia 
(38.8 ºC), arterial hypertension (153/90 mmHg), and 
leukocytosis (leukocytes 39,600/mm³, with 84% segmented 
and 4% rods). New CSF analysis showed lymphocytic 
pleocytosis that was culture positive to K. pneumoniae, 
which was resistant to most antibiotics tested, including 
all β-lactams and gentamicin. However, it was susceptible 
to amikacin, ciprofloxacin and polymyxin (MIC=0.25). 
Analysis of β-lactamase genes revealed the presence of 
bla-TEM, bla-SHV, and bla-KPC genes. The isolate was identified 
as sequence type 1298.
Because of his clinical condition and decreasing 
consciousness level, IV polymyxin E 150 mg/12 h was 
added to his treatment for 19 days. Meropenem was 
maintained following CSF culture results, with the dose 
increased to 2 g/8 h. Despite improved CSF parameters, 
intrathecal polymyxin E (5 mg/day for 3 days and then every 
other day to complete 7 days of treatment) was introduced. 
The patient was discharged 37 days after admission with 
a GCS score of 15 and no CSF abnormalities (Table 1). 
Case 2
A 50-year-old woman from Sao Gabriel do Oeste, Mato 
Grosso do Sul State (MS), Brazil, presented with severe 
traumatic brain injury and loss of consciousness after a fall 
from her own height. The Emergency Mobile Care Service 
classified the patient as having a severe condition with a 
cephalic contusion of 3 cm, GCS score of 7/15, anisocoric 
pupils, normal blood pressure (110/70 mmHg) and normal 
cardiopulmonary auscultation. She had a history of mental 
disorder due to cerebral palsy, arterial hypertension and 
diabetes mellitus.
The patient was transferred to a tertiary hospital in 
Campo Grande, MS. On admission, she was sedated and 
intubated after first aid. She had a GCS score of 4/15, 
isochoric pupils, lack of motor response, hypotension, heart 
rate of 130 beats/min and no respiratory abnormalities. 
Cranial CT showed subarachnoid hemorrhage with 
left frontal hematoma, cerebral edema and intracranial 
hypertension. She was classified as grade 4 on the Fisher 
scale for subarachnoid hemorrhage and underwent an 
external ventricular derivation surgery. On hospitalization 
day 4, the patient developed pneumonia. The chest 
radiograph showed opacity in the right lower lobe of the 
lung. Intravenous piperacillin/tazobactam 0.5 g plus4 g/6 h 
and IV linezolid 600 mg/12 h were administered for 7 and 
10 days respectively, to treat the nosocomial pneumonia. 
After hospitalization day 16, fever developed (38.8 °C). 
Because her clinical condition worsened, IV polymyxin 
Table 1 - Case 1 cerebrospinal fluid characteristics compatible 




3 11 21 36 
White blood cell (mm³) 6 21,000 40 1
Red blood cell (mm³) 800 800 45 3
Neutrophils (%) - 04 95 -
Lymphocytes/Monocytes (%) - 96 5 -
Proteins (mg/dL) 10 1,336 75 37
Glucose (mg/dL) 77 10 41 52
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E 150 mg/12 h for 7 days and IV meropenem 1 g/8 h for 
9 days were initiated. Intrathecal polymyxin E (5 mg/day 
for 3 days, followed by its use on every other day to 
complete 14 days of treatment) was administered because 
fever and GCS score of 3/15 persisted. This medication 
was introduced based on CSF results on day 18 (Table 2). 
CSF analysis showed pleocytosis with neutrophil 
predominance and K. pneumoniae grew on culturing. 
Antimicrobial susceptibility testing showed sensitivity to 
amikacin, gentamicin and polymyxin B (MIC=0.5 µg/mL) 
and resistance to all β-lactam antibiotics. K. pneumoniae 
harbored bla-CTX-M, bla-SHV, and bla-KPC genes. The strain 
belonged to clone ST 2687 in MLST. Due to favorable 
clinical and laboratory results, after hospitalization day 
46, the patient was transferred to a hospital in Sao Gabriel 
do Oeste, MS, so that we do not have further information 
about her. 
DISCUSSION
Nosocomial bacterial meningitis,  especially 
carbapenem-resistant intracranial bacterial infections, are 
life-threatening complications in neurosurgical patients11,12. 
The most frequent causative agents of health-care-associated 
meningitis are Staphylococcus spp. and multidrug-resistant 
and extensively drug-resistant gram-negative bacteria, 
including Acinetobacter baumannii, Pseudomonas 
aeruginosa, Escherichia coli and K. pneumoniae13. 
K. pneumoniae causes several nosocomial infections. The 
most common sites of CRKP infection are the respiratory 
system, urinary tract and bloodstream. CRKP is rarely 
isolated from CSF samples4,5,14. 
Meningitis caused by CRKP post-neurosurgery has been 
reported in many countries, including Turkey15, USA5 and 
China16. In Brazil, Tuon et al.17 described for the first time 
a nosocomial KPC-producing K. pneumoniae meningitis in 
the South region. To our knowledge, these are the first CRKP 
meningitis cases described in the Midwest of Brazil. Invasive 
procedures, including mechanical ventilation and central 
venous catheterization are associated with the acquisition of 
multi-resistant bacteria. Surgery is a risk factor for CRKP 
infections16. Infections after head trauma, similar to our cases, 
followed by neurosurgical procedures and gram-negative 
meningitis/ventriculitis, have been reported11.
Diagnosis of meningitis can be difficult. CSF cultures 
are the most important test to diagnose healthcare-associated 
ventriculitis and meningitis13. Although bacteriological CSF 
cultures from Case 1 on day 11 indicated CRKP and CSF 
parameters were consistent with meningitis, lymphocytosis 
was initially present. Lymphocytosis may be present as a 
component of acute bacterial meningitis mainly in neonatal 
and pediatric patients18,19. The emergence of CRKP 
infections is a rising public health threat associated with 
extremely high morbidity and mortality rates that demand 
caution with antibiotic use12,16.
In our two cases, we observed K. pneumoniae isolates 
co-producing extended-spectrum β-lactamases (ESBLs) 
and KPC enzymes. ESBLs of TEM, SHV and CTX-M types 
are very common among Klebsiella spp9. ESBL-producing 
K. pneumoniae may be more invasive and resistant and 
the distribution of these bacteria varies according to 
geographical areas20. CRKP is already endemic in many 
countries, including Brazil. This mechanism confers a high 
resistance to β-lactams, including carbapenems3,20. A study 
conducted in Mato Grosso do Sul State reported a high rate 
(93.3%) of CRKP in that region21. Genetic polymorphism 
analyses of the two K. pneumoniae isolates revealed two 
different clones: ST1298 and ST2687. In Brazil, sequence 
types ST11, ST437, and ST340 are more frequently reported 
among K. pneumoniae isolates, while ST258 are the most 
frequently associated with KPC enzyme production in 
Europe and the USA22. Here, we report for the first time the 
involvement of ST1298 and ST2687 in meningitis caused 
by CRKP. Treatment of central nervous system infections 
is more limited than those of bloodstream and pulmonary 
infections. There are limited data on optimal dosing and 
brain barrier penetration of most agents administered to treat 
carbapenem-resistant Enterobacteriaceae infections6,23. 
CRKP infections are treated with combination therapies, 
including polymyxin or tigecycline with carbapenems, 
aminoglycosides, fluoroquinolones or fosfomycin22. A 
high carbapenem MIC (MIC ≥8µg/mL) predicts a lower 
response to the antibiotic23. The relatively new antimicrobial 
ceftazidime-avibactam (approved in 2014 by the U.S. Food 
and Drug Administration, USA) has been successfully 
used for treating CRKP meningitis. The drug is less toxic 
and can inhibit KPC-2 carbapenemase and group C beta-
lactamases5. Ceftazidime-avibactam has a great treatment 
Table 2 - Case 2 cerebrospinal fluid characteristics compatible 





White blood cell (mm³) 8 1,100 73 
Red blood cell (mm³) 1,230 12,160 420 
Neutrophils (%) - 73 78 
Lymphocytes/Monocytes (%) - 27 22
Proteins (mg/dL) 248 462 233 
Glucose (mg/dL) 58 21 38
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potential because of its direct action on the carbapenem 
resistance mechanism. However, this option was not 
available for the reported cases. Although intravenous 
polymyxins poorly penetrate the CSF and they present 
with high pharmacokinetic variability, the combination of 
intravenous polymyxin E and intrathecal polymyxin showed 
satisfactory responses with resolution of meningitis23. 
We reported two rare cases of meningitis caused by 
CRKP that were satisfactorily treated with intravenous 
polymyxin and intrathecal polymyxin, despite the 
associated high mortality reported in literature. 
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